Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.63 |
| ▸ | MMP3 | P08254 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL5438521 | 0.97 | ENPP2 (0.61) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL7196848 | 0.89 | ENPP2 (0.53) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL31019583 | 0.89 | ENPP2 (0.53) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL4374157 | 0.89 | ENPP2 (0.58) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL13001900 | 0.89 | ENPP2 (0.53) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL24087989 | 0.89 | ENPP2 (0.53) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL6753195 | 0.89 | ENPP2 (0.53) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL2944694 | 0.89 | ENPP2 (0.53) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL7557664 | 0.87 | ENPP2 (0.52) | ENPP2MMP3KMT2AMEN1KDM4E | |
| SCHEMBL30504282 | 0.85 | MMP3 (0.79) | ENPP2MMP3KMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118156493-A | Modified anode material, modification method and application thereof | 湖南中科星城石墨有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-118063350-A | sp2Carbon bond linked porous organic molecular cage material, preparation and application thereof | 中国科学院福建物质结构研究所 | 2024-05-24 | — | — | CN | claimed |
| CN-114914536-A | Electrolyte for lithium battery, and method for improving performance of high-temperature lithium battery | 中国科学院物理研究所 | 2022-08-16 | — | — | CN | claimed |
| US-20150133628-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2015-05-14 | — | — | US | claimed |
| US-20130123542-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2013-05-16 | — | — | US | claimed |
| EP-2522688-A1 | POLYAMINE AND METHOD FOR PRODUCING THE SAME | Rhodia Operations (FR) | 2012-11-14 | — | — | EP | claimed |
| US-7923110-B2 | Metal nanoparticle having a self-assembled monolayer on its surface, and formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-04-12 | — | — | US | claimed |
| US-7858241-B2 | Nonaqueous electrolyte for lithium secondary battery and lithium secondary batter using the same | SAMSUNG SDI CO., LTD. (KR) | 2010-12-28 | — | — | US | claimed |
| US-20080311481-A1 | NONAQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTER USING THE SAME | SAMSUNG SDI CO., LTD (KR) | 2008-12-18 | — | — | US | claimed |
| US-20080020317-A1 | Novel metal nanoparticle and formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-24 | — | — | US | claimed |
| US-20080003363-A1 | Novel metal nanoparticle and method for formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-03 | — | — | US | claimed |
| US-5753757-A | Electroluminescent polymer compositions and processes thereof | XEROX CORPORATION (US) | 1998-05-19 | — | — | US | claimed |
| US-12637492-B2 | Peptide inhibitors of focal adhesion kinase activity and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260070901-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTPR LTD (GB) | 2026-03-12 | — | — | US | disclosed |
| US-12521386-B2 | Small molecule inhibitors of the androgen receptor activity and/or expression and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2026-01-13 | — | — | US | disclosed |
| US-12509468-B2 | Quindoline compounds and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-12-30 | — | — | US | disclosed |
| EP-0186330-A1 | \"Living\" polymers and chain transfer-regulated polymerization process | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-07-02 | — | — | EP | disclosed |
| US-4554345-A | Preparation of liquid polyamide from dinitrile and diamine | THE STANDARD OIL COMPANY (US) | 1985-11-19 | — | — | US | disclosed |
| US-4380623-A | Preparation of polyamide from dinitrile, diamine, water, and CO2 catalyst | STANDARD OIL COMPANY (US) | 1983-04-19 | — | — | US | disclosed |
| US-4142029-A | Bis-tetrazoles as chemical blowing agents for foaming thermoplastic resins | CIBA-GEIGY CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509468-B2 | Quindoline compounds and uses thereof | TPD52L2, BRDT, RECQL | ENPP2 4237/4885MMP3 4075/4885KMT2A 379/4885 |
| US-20260070901-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CSNK1A1, CSNK2A3, CSNK1G1 | ENPP2 4092/4885MMP3 3898/4885KMT2A 250/4885 |
| US-12637492-B2 | Peptide inhibitors of focal adhesion kinase activity and uses thereof | PTK2, ILK, FPR2 | ENPP2 515/4885MMP3 882/4885KMT2A 4001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.